OSA treatment on cardio- and cerebrovascular comorbidities: A long-term nationwide cohort study

Authors

Kun-Lin Yang, Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan and Kaohsiung, Taiwan.
Pei-Wen Lin, Division of Glaucoma, Department of Ophthalmology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan and Kaohsiung, Taiwan.
Chun-Tuan Chang, Department of Business Management, National Sun Yat-sen University, Kaohsiung, Taiwan.Follow
Pi-Hua Liu, Clinical Informatics and Medical Statistics Research Center, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Hsin-Ching Lin, Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan and Kaohsiung, Taiwan.
Michael Friedman, Advocate Aurora HealthFollow
Anna M. Salapatas, Division of Sleep Surgery, Department of Otolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, Illinois, USA.

Recommended Citation

Yang KL, Lin PW, Chang CT, et al. OSA Treatment on Cardio- and Cerebrovascular Comorbidities: A Long-term Nationwide Cohort Study. Otolaryngol Head Neck Surg. 2022;167(3):600-606. doi:10.1177/01945998211065656

Affiliations

Advanced Center for Specialty Care, Advocate Illinois Masonic Medical Center, Chicago

Abstract

Objective: To compare the cardio- and cerebrovascular outcomes and survival rates of surgical and nonsurgical interventions for patients with obstructive sleep apnea (OSA) based on a national population-based database.

Study design: Retrospective cohort study.

Setting: Taiwan National Health Insurance Research Database.

Methods: We analyzed all cases of OSA among adults (age >20 years and confirmed with ICD-9-CM) from January 2001 to December 2013. We compared the patients with OSA who received upper airway surgery with age-, sex-, and comorbidity index-matched controls with continuous positive airway pressure (CPAP) treatment. The risk of myocardial infarction (MI) or stroke after treatment of OSA-related surgery versus CPAP was investigated.

Results: During follow-up, 112 and 92 incident cases of MI occurred in the OSA surgery and CPAP treatment groups, respectively (rates of 327 and 298 per 100,000 person-years). Furthermore, 50 and 39 cases were newly diagnosed with stroke in the OSA surgery and CPAP treatment groups (rates of 144 and 125 per 100,000 person-years). Cox proportional hazard regressions showed that the OSA treatment groups (OSA surgery vs CPAP) were not significantly related to MI (hazard ratio, 1.03 [95% CI, 0.781-1.359]; P = .833) and stroke (hazard ratio, 1.12 [95% CI, 0.736-1.706]; P = .596) at follow-up, after adjustment for sex, age at index date, days from diagnosis to treatment, and comorbidities.

Conclusion: Our study demonstrated that there was no difference of cardio- and cerebrovascular results between CPAP and surgery for patients with OSA in a 13-year follow-up.

Document Type

Article

PubMed ID

34905426